The inaugural NCI/SNO Symposium on “Targeting CNS Tumor Metabolism” will foster collaboration in the area of metabolism which will positively influence outcomes for patients with CNS cancers. This is the first conference that focuses on the tumor metabolism and it is expected to be both didactic as well as a collegial learning environment with the goal to enhance partnerships and advance the treatment for patients. Metabolic investigations for these tumors have been conducted in isolation and the goal of this meeting is to bring together the clinicians with the experts in metabolism in order to increase the utilization of metabolic investigations in the clinical settings.
Participants will gain new understanding in CNS tumor metabolism via the use of state-of-the-art techniques; the interaction between the metabolism and the other -omics such as epigenomics, transcriptomics, as well as the current standard of care; and the challenges in targeting the metabolic signaling pathways.
Topics to be covered over this two-day event include:
- Epigenome, Transcriptome, Metabolome and Modeling
- Metabolic Fluxes and Signaling of Metabolic Pathways
- New Technologies for Studying Brain Metabolism
- Metabolic Biomarkers and Imaging
- Metabolic Drug Targets, Resistance
Confirmed speakers to date:
- Paul Mischel, MD, Distinguished Professor, University of California San Diego
- Craig Thompson, MD, President and CEO, Memorial Sloan Kettering Cancer Center
- Daniel Cahill, MD, PhD, Harvard Medical School
- Sabrina Ronen, PhD, University of California, San Francisco
- Ovidiu Andronisei, MD, PhD, Harvard Medical School
- Christian Metallo, PhD, University of California San Diego
- Houtan Noushmehr, PhD, Henry Ford Cancer Institute
Scientific Program Committee
Trainee Travel Grants
- Mioara Larion, PhD, National Institutes of Health (NCI Program Co-Chair)
- Elizabeth Maher, MD, PhD, UT Southwestern Medical Center (SNO Program Co-Chair)
- Mark Gilbert, MD, National Institutes of Health (NCI Institutional Chair)
- Gelareh Zadeh, MD, PhD, University of Toronto (SNO Institutional Chair)
Thanks to the generosity of the Dabbiere family, ten trainee travel grants will be available for this meeting. The grant will cover registration, hotel, and $500 to cover travel expenses. To be eligible, recipients must be currently no more than 5 years after obtaining their terminal degree, have an active interest in brain tumor research, and be the first and presenting author on the submitted abstract.
Please click on the individual quick links to the right for details as they become available. We look forward to seeing you in April 2021!